This bill aims to eliminate the termination date for the prohibition against pharmacy benefit managers or health carriers requiring federally certified health entities to identify 340B drugs. It specifically repeals Section 26 of Chapter 501 from the Laws of 2021 and Section 1 of Chapter 259 from the Laws of 2023, thereby extending the existing prohibition indefinitely.

Additionally, the bill includes a provision for an immediate effective date, meaning that the changes will take effect as soon as the bill is passed and approved. This legislative action seeks to ensure that the requirements regarding 340B drugs remain in place without a predetermined end date.